Viruses (Apr 2023)

Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice

  • Yasmin da Silva Santos,
  • Thais Helena Martins Gamon,
  • Marcela Santiago Pacheco de Azevedo,
  • Bruna Larotonda Telezynski,
  • Edmarcia Elisa de Souza,
  • Danielle Bruna Leal de Oliveira,
  • Jamille Gregório Dombrowski,
  • Livia Rosa-Fernandes,
  • Giuseppe Palmisano,
  • Leonardo José de Moura Carvalho,
  • Maria Cecília Rui Luvizotto,
  • Carsten Wrenger,
  • Dimas Tadeu Covas,
  • Rui Curi,
  • Claudio Romero Farias Marinho,
  • Edison Luiz Durigon,
  • Sabrina Epiphanio

DOI
https://doi.org/10.3390/v15040999
Journal volume & issue
Vol. 15, no. 4
p. 999

Abstract

Read online

Since December 2019, the world has been experiencing the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we now face the emergence of several variants. We aimed to assess the differences between the wild-type (Wt) (Wuhan) strain and the P.1 (Gamma) and Delta variants using infected K18-hACE2 mice. The clinical manifestations, behavior, virus load, pulmonary capacity, and histopathological alterations were analyzed. The P.1-infected mice showed weight loss and more severe clinical manifestations of COVID-19 than the Wt and Delta-infected mice. The respiratory capacity was reduced in the P.1-infected mice compared to the other groups. Pulmonary histological findings demonstrated that a more aggressive disease was generated by the P.1 and Delta variants compared to the Wt strain of the virus. The quantification of the SARS-CoV-2 viral copies varied greatly among the infected mice although it was higher in P.1-infected mice on the day of death. Our data revealed that K18-hACE2 mice infected with the P.1 variant develop a more severe infectious disease than those infected with the other variants, despite the significant heterogeneity among the mice.

Keywords